Search for Clinical Trials
Phase I study of autologous T lymphocytes expressing GD2-specific chimeric antigen and constitutively active IL-7 receptors for the treatment of…
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy)…
The investigators are conducting this study with men that have prostate cancer and are getting standard of care treatment with the drugs abiraterone…
The purpose of this study is to find the largest safe dose of GD2-C7R T cells, and also to evaluate how long they can be detected in the blood and…
The purpose of this study is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a…
The purpose of this study is to find the largest effective and safe dose of GD2-CAR NKT cells to evaluate their effect on the tumor and how long they…
This research study combines antibodies and T cells to fight a type of blood cancer called T-cell leukemia or lymphoma (lymph gland cancer).
The purpose of this study is to investigate if meclizine, a CAR inverse agonist, will have a beneficial therapeutic effect in patients with…
In this study lymphodepletion chemotherapy will be administered in patients who are not post autologous transplant in the hope that it will result in…
The purpose of this study is to determine the safety and efficacy of KTE-C19 in relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) in…
